102 related articles for article (PubMed ID: 11747623)
1. Development of a highly purified multicomponent leukocyte IFN-alpha product.
Tölö H; Kauppinen HL; Alm G; Perers A; Lindeberg E; Wahlstedt-Fröberg V; Parkkinen J
J Interferon Cytokine Res; 2001 Nov; 21(11):913-20. PubMed ID: 11747623
[TBL] [Abstract][Full Text] [Related]
2. Long-term stabilization of a new freeze-dried and albumin-free formulation of recombinant human interferon alpha 2b.
Ruiz L; Reyes N; Sotolongo J; Aroche K; Aldana R; Báez R; Hardy E
PDA J Pharm Sci Technol; 2006; 60(1):72-8. PubMed ID: 17089680
[TBL] [Abstract][Full Text] [Related]
3. Molecular and biologic characterization of recombinant interferon-alpha2b.
Bordens R; Grossberg SE; Trotta PP; Nagabhushan TL
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-41-S9-51. PubMed ID: 9208872
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the antiviral activities of natural IFN-alpha preparations and their subtype compositions.
Yanai Y; Sanou O; Kayano T; Ariyasu H; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M
J Interferon Cytokine Res; 2001 Oct; 21(10):835-41. PubMed ID: 11710996
[TBL] [Abstract][Full Text] [Related]
5. Purification of an acid-stable bovine leukocyte interferon.
Abolhassani M; Jacobsen KL
Vet Immunol Immunopathol; 1991 Aug; 29(1-2):171-81. PubMed ID: 1949578
[TBL] [Abstract][Full Text] [Related]
6. Identification of nine interferon-alpha subtypes produced by Sendai virus-induced human peripheral blood leucocytes.
Nyman TA; Tölö H; Parkkinen J; Kalkkinen N
Biochem J; 1998 Jan; 329 ( Pt 2)(Pt 2):295-302. PubMed ID: 9425112
[TBL] [Abstract][Full Text] [Related]
7. Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factors.
Palmer P; Tovey MG; Raschilas F; Brassart L; Meritet JF; Porcher R; Lebon P
Eur Cytokine Netw; 2007 Jun; 18(2):108-14. PubMed ID: 17594944
[TBL] [Abstract][Full Text] [Related]
8. Affinity purification of recombinant interferon-alpha on a mimetic ligand adsorbent.
Swaminathan S; Khanna N
Protein Expr Purif; 1999 Mar; 15(2):236-42. PubMed ID: 10049681
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha 2 produced by normal human leukocytes is predominantly interferon-alpha 2b.
Dipaola M; Smith T; Ferencz-Biro K; Liao MJ; Testa D
J Interferon Res; 1994 Dec; 14(6):325-32. PubMed ID: 7897251
[TBL] [Abstract][Full Text] [Related]
10. Priming with interferon-alpha 1 or interferon-alpha 2 enhances the production of both subtypes simultaneously.
Fuchsberger N; Karayianni-Vasconcelos G; Kauppinen HL; Hajnicka V; Kontsek P
J Interferon Cytokine Res; 1995 Jul; 15(7):637-9. PubMed ID: 7553235
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of recombinant, glycosylated human interferon alpha 2b in murine myeloma NSo cells.
Rossmann C; Sharp N; Allen G; Gewert D
Protein Expr Purif; 1996 Jun; 7(4):335-42. PubMed ID: 8776749
[TBL] [Abstract][Full Text] [Related]
12. Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-alpha by monoclonal antibodies.
Viscomi GC; Antonelli G; Bruno C; Scapol L; Malavasi F; Funaro A; Simeoni E; Pestka S; De Pisa F; Dianzani F
J Interferon Cytokine Res; 1999 Apr; 19(4):319-26. PubMed ID: 10334382
[TBL] [Abstract][Full Text] [Related]
13. Circumventing the heterogeneity and instability of human serum albumin-interferon-alpha2b fusion protein by altering its orientation.
Zhao HL; Xue C; Wang Y; Li XY; Xiong XH; Yao XQ; Liu ZM
J Biotechnol; 2007 Sep; 131(3):245-52. PubMed ID: 17698234
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of magnetic microspheres for the purification of interferon alpha-2b.
Cao Y; Bai G; Chen J; Tian W; Wang S; Yang W
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 833(2):236-44. PubMed ID: 16490407
[TBL] [Abstract][Full Text] [Related]
15. Binding Characteristics of IFN-alpha Subvariants to IFNAR2-EC and Influence of the 6-Histidine Tag.
Schmeisser H; Kontsek P; Esposito D; Gillette W; Schreiber G; Zoon KC
J Interferon Cytokine Res; 2006 Dec; 26(12):866-76. PubMed ID: 17238829
[TBL] [Abstract][Full Text] [Related]
16. Rapid production of interferon-gamma in uninduced human leukocyte suspensions.
Cantell K; Hirvonen S; Kauppinen HL; Kalkkinen N
J Interferon Res; 1991 Aug; 11(4):231-6. PubMed ID: 1919078
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of natural human interferon omega 1. Two alternative cleavage sites for the signal peptidase.
Adolf GR; Maurer-Fogy I; Kalsner I; Cantell K
J Biol Chem; 1990 Jun; 265(16):9290-5. PubMed ID: 1693148
[TBL] [Abstract][Full Text] [Related]
18. Porcine leukocyte interferon exhibits close antigenic relatedness to human interferon alpha 2, but not to human interferon alpha 1.
Karayianni-Vasconcelos G; Borecký L; Kontsek P
Vet Immunol Immunopathol; 1993 Oct; 38(3-4):359-65. PubMed ID: 7507275
[TBL] [Abstract][Full Text] [Related]
19. The human interferon-alpha species and hybrid proteins.
Pestka S
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-4-S9-17. PubMed ID: 9208870
[TBL] [Abstract][Full Text] [Related]
20. Studies on silica-bonded monoclonal antibody packing material for separation of recombinant interferon by high performance immunoaffinity chromatography.
Feng W; Geng X
Biomed Chromatogr; 1993; 7(6):317-20. PubMed ID: 8298288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
